Asset Management One Co. Ltd. reduced its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 51,498 shares of the company's stock after selling 3,661 shares during the quarter. Asset Management One Co. Ltd.'s holdings in Henry Schein were worth $3,626,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Cromwell Holdings LLC grew its holdings in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Studio Investment Management LLC grew its holdings in shares of Henry Schein by 3.8% during the 3rd quarter. Studio Investment Management LLC now owns 4,674 shares of the company's stock valued at $341,000 after purchasing an additional 172 shares during the last quarter. Central Pacific Bank Trust Division grew its holdings in shares of Henry Schein by 2.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock valued at $706,000 after purchasing an additional 200 shares during the last quarter. Huntington National Bank grew its holdings in shares of Henry Schein by 16.8% during the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company's stock valued at $110,000 after purchasing an additional 218 shares during the last quarter. Finally, Bridge Creek Capital Management LLC grew its holdings in shares of Henry Schein by 0.7% during the 4th quarter. Bridge Creek Capital Management LLC now owns 38,763 shares of the company's stock valued at $2,682,000 after purchasing an additional 260 shares during the last quarter. 96.62% of the stock is owned by institutional investors.
Henry Schein Trading Down 1.0 %
Shares of NASDAQ HSIC traded down $0.81 during midday trading on Friday, reaching $77.24. The stock had a trading volume of 3,295,278 shares, compared to its average volume of 1,668,216. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company's 50 day moving average price is $74.14 and its 200 day moving average price is $72.21. The firm has a market cap of $9.63 billion, a price-to-earnings ratio of 31.79, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91.
Analyst Ratings Changes
Several research firms recently commented on HSIC. Barrington Research lifted their target price on shares of Henry Schein from $82.00 to $90.00 and gave the stock an "outperform" rating in a research report on Thursday, January 30th. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and lifted their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price on the stock. Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price on the stock. Finally, Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Eight equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $80.09.
Get Our Latest Research Report on HSIC
Henry Schein Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.